Literature DB >> 31345547

Targeting Arterial Oxygen Saturation by Closed-Loop Control of Inspired Oxygen in Preterm Infants.

Nelson Claure1, Eduardo Bancalari2.   

Abstract

Exposure to hyperoxemia from excessive oxygen supplementation and episodes of intermittent hypoxemia have been associated with damage to the eye, lung, and central nervous system in premature infants. The inherent respiratory instability of the premature infant combined with limited staffing or equipment resources often affect SpO2 targeting and increase exposure to extreme SpO2 levels. Multiple systems for closed loop control of inspired oxygen have been developed to improve SpO2 targeting. This article reviews the evidence provided by clinical studies evaluating the efficacy of these systems in extreme premature infants.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Automatic; Oxygen therapy; Oxygenation; Premature infant; Supplemental oxygen

Mesh:

Substances:

Year:  2019        PMID: 31345547     DOI: 10.1016/j.clp.2019.05.007

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  4 in total

1.  Clinical Evaluation of an Automatic Oxygen Control System for Premature Infants Receiving High-Flow Nasal Cannula for Respiratory Support: A Pilot Study.

Authors:  Xuefeng Hou; Akram Faqeeh; Ramak Amjad; John Pardalos; Roger Fales
Journal:  J Med Device       Date:  2022-05-10       Impact factor: 0.743

2.  What is BPD today and in the next 50 years?

Authors:  Richard J Martin; Alan H Jobe; Eduardo Bancalari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-13       Impact factor: 6.011

Review 3.  The relationship between intermittent hypoxemia events and neural outcomes in neonates.

Authors:  Juliann M Di Fiore; Thomas M Raffay
Journal:  Exp Neurol       Date:  2021-05-10       Impact factor: 5.620

4.  Intermittent Hypoxemia and Bronchopulmonary Dysplasia: Manifestations of Immature Respiratory Control and the Preterm Lung.

Authors:  Juliann M Di Fiore; Richard J Martin; Thomas M Raffay
Journal:  Am J Respir Crit Care Med       Date:  2021-11-15       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.